Navigation Links
Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS)
Date:6/23/2011

neurological illness could make donations that can support investigator-initiated clinical trials. The Center hopes to optimize proper treatments in order to improve outcomes for patients with neurological diseases. For more information on the Center, please visit its website at www.pnaresearch.org.

About AEN-100 and AEN-200

AEN-100 is Adeona's proprietary, once-daily, gastroretentive, sustained-release oral tablet formulation of zinc acetate. AEN-200 is Adeona's proprietary oral tablet formulation of copper sulfate.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company's primary strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is preparing to make reaZinTM, a prescription medical food for the dietary management of zinc deficiency associated with Alzheimer's disease, commercially available. In addition, the Company is developing, or has partnered the development of, drug product candidates to treat multiple sclerosis, fibromyalgia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease and age-related macular degeneration. For more information, please visit Adeona's website at www.adeonapharma.com.

RILUTEK® (riluzole) is a registered trademark of sanofi-aventis U.S. LLC.

This release includes forward-looking statements on Adeona's current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "could," "potential," "positions," "continue," "expects," "anticipates," "intends," "plans," "believe," "estimates," and similar expressions. These stateme
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Adeona Announces HartLab Expansion Into Microbiology Testing Services
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Adeona Announces Second Quarter 2010 Profitability and Achievements
4. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
5. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
6. Adeona to Hold Annual Shareholder Meeting
7. Adeona Announces Third Quarter 2010 Financial Results and Achievements
8. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
9. Adeona to Present at OneMedForum San Francisco 2011 Conference
10. Adeona to Host Investor Day on Zinc Deficiency in Alzheimers Disease
11. Adeona to Raise $4 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... JERUSALEM , May 17, 2013 ... a developer of oral drug delivery systems, announced today ... has cleared the Company,s Investigational New Drug application(IND) for ... very pleased to have the FDA clearance to proceed," ... Oramed. "The upcoming trial is a major milestone for ...
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation ... at the annual EuroPCR Scientific Program May 21-24 in ... pleased to present a particularly rich and diversified set ... Keith Dawkins , M.D., global chief medical officer, ... will be presented, including the NG PROMUS trial, which ...
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 ... ABBV ) announced today an extension of ... Galapagos will fund and complete a Phase 2 program ... progression into Phase 3.  Upon successful completion of the ... $50 million.  The terms of the collaboration extension are ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... (Nasdaq: HOLX ) today announced that Rob ... the 2010 Morgan Stanley Global Healthcare Conference on Tuesday, ... Interested parties are invited to listen to the live ... section of the company,s website at www.hologic.com/investors-overview . ...
... Fall Conference at Maui, Hawaii From September 1 -... -- CHENGDU, China, Aug. 30 /PRNewswire-Asia-FirstCall/ -- ... ... lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 2Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 3Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 4Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 5Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 6
(Date:5/18/2013)... Orlando, FL (May 18, 2013) There are ... procedures commonly used to diagnose or treat gastrointestinal ... Week (DDW). , A study by New ... that more objective testing may substantially reduce the ... (GERD). Although GERD is believed to affect nearly ...
(Date:5/18/2013)... Today, Zane Benefits, Inc. published ... in Marketplaces . Zane Benefits, which provides comprehensive ... benefits, is the leader in health care reform, ... arrangements . , According to Zane Benefits’ website, ... recently released a much-anticipated statement and Q&A on ...
(Date:5/18/2013)... York, NY (PRWEB) May 18, 2013 After ... consistent efforts, SizeItUp formally announced the integration of ... redesigned 2012 Hyundai Genesis is set to stun the automobile ... and style. 2012 Hyundai Genesis is marked as the latest ... and heads the vehicles lined up for the year 2013. ...
(Date:5/18/2013)... May 18, 2013 Although obesity is ... the association between obesity and esophageal adenocarcinoma, a type ... obesity-related tumors. As reported on Cancer.gov, last ... almost twice as likely as those of normal and ... relationship between obesity and esophageal cancer is not well ...
(Date:5/18/2013)... TX (PRWEB) May 18, 2013 Show And ... years of various different training systems that is all about ... has caught the attention of http://ShowAndGoTrainingReview.com ’s Stan ... Training is a unique “four phase system” designed to ... minimum amount of time spent working out in the gym. ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... XLHealth, owner of one of the nation,s largest Medicare ... improving the quality of care for seniors with chronic ... to serve as its vice president of contracting and ... for the establishment, strategic planning, and management for the ...
... 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ... Phase 3b study that found VYVANSE (lisdexamfetamine dimesylate) CII ... a simulated workplace environment study in adults with Attention ... approved stimulant for adults with ADHD to be evaluated ...
... , Partnership to Fund $240 Million in New Services, ... , , MANASSAS, Va. and WINSTON-SALEM, N.C. ... the Federal Trade Commission and the Virginia Attorney General, ... Novant Health of North Carolina, both non-profit organizations, announced ...
... Christian Children,s Fund, one of the world,s ... The new name takes effect today. , , ... strategy to meet the needs of children today and tomorrow. ... million children and family members in 31 countries. , ...
... , Unified Blue Cross Blue Shield Brand Strengthens Competitive Position , ... Virgin Islands , , SAN JUAN, Puerto ... GTS ) today announced that Triple-S Salud, Inc., its managed ... assets of La Cruz Azul de Puerto Rico, Inc. for approximately $10.5 ...
... Web-Based Fraud Prevention Tools Can Reduce Medical Identity Theft , ... Corporation , a leading provider of data enhancement, verification, ... to assist health care organizations prepare for enforcement of the ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090701/PH40278LOGO ) , , According ...
Cached Medicine News:Health News:XLHealth Appoints New Vice President of Contracting and Provider Relations 2Health News:VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 2Health News:VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 3Health News:VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 4Health News:Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia 2Health News:Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia 3Health News:Christian Children's Fund Name Change to ChildFund International Official 2Health News:Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc. 2Health News:Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc. 3Health News:Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc. 4Health News:CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule 2Health News:CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: